NRC Health (NRC) reported fourth‑quarter 2025 revenue of $35.19 million, a decline of roughly 4.5% year‑over‑year from $38.00 million in Q4 2024 and $38.00 million in Q4 2023. The figure also represents a 2% quarter‑over‑quarter increase, reflecting a modest rebound in demand for its core patient‑experience platform.
NRC’s operating income fell to $4.67 million from $9.59 million in the same quarter a year earlier, a 51% drop that mirrors the revenue contraction and the company’s higher operating‑expense load. Operating margin slipped from 12.3% to 13.3% of revenue, a compression driven by the accelerated spend on AI‑enabled analytics and the integration of the recently acquired Nobl Health.
Basic earnings per share dropped to $0.08 from $0.28, a 71% decline that reflects both the revenue shortfall and the margin squeeze. The loss of $0.20 per share is largely attributable to the higher cost base and the one‑time restructuring charges associated with the AI platform rollout.
Total operating expenses rose to $30.53 million from $27.32 million, an increase of $3.21 million. The jump is largely due to higher research and development outlays for AI capabilities, increased sales and marketing spend to support the Nobl Health integration, and higher general and administrative costs linked to the company’s expansion into new geographic markets.
Cash flow from operations increased 13% to $7.20 million, the highest quarterly figure since Q4 2024. The stronger cash generation, despite lower earnings, signals that NRC’s core operations remain cash‑productive and that the company can fund its strategic investments without external financing.
CEO Trent Green said the quarter demonstrated “strong, disciplined execution” and that momentum is building across the portfolio. He emphasized the company’s focus on AI‑driven transformation and the disciplined management of operating expenses, noting that the investments are expected to pay off in the medium term as the platform scales.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.